BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 25070762)

  • 21. Outcomes of Pediatric ABO-incompatible Living Kidney Transplantations From 2002 to 2015: An Analysis of the Japanese Kidney Transplant Registry.
    Hattori M; Mieno M; Shishido S; Aikawa A; Ushigome H; Ohshima S; Takahashi K; Hasegawa A;
    Transplantation; 2018 Nov; 102(11):1934-1942. PubMed ID: 29781948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cascade plasmapheresis as preconditioning regimen for ABO-incompatible renal transplantation: a single-center experience.
    Jha PK; Tiwari AK; Bansal SB; Sethi SK; Ahlawat R; Kher V
    Transfusion; 2016 Apr; 56(4):956-61. PubMed ID: 26592368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Chow KV; Flint SM; Shen A; Landgren A; Finlay M; Murugasu A; Masterson R; Hughes P; Cohney SJ
    Transplantation; 2017 Jun; 101(6):1433-1440. PubMed ID: 27495772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.
    Genberg H; Kumlien G; Wennberg L; Berg U; Tydén G
    Transplantation; 2008 Jun; 85(12):1745-54. PubMed ID: 18580466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Stockholm experience with ABO-incompatible kidney transplantations without splenectomy.
    Tydén G; Kumlien G; Genberg H; Sandberg J; Sedigh A; Lundgren T; Gjertsen H; Fehrman I
    Xenotransplantation; 2006 Mar; 13(2):105-7. PubMed ID: 16623801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term desensitization for ABO-incompatible living related kidney transplantation recipients with high refractory and rebound anti-blood type antibody: case report.
    Nishimura H; Yamada Y; Hisano S; Mitsuke A; Tatarano S; Gotanda T; Hayami H; Nakagawa M; Enokida H
    BMC Nephrol; 2018 Oct; 19(1):254. PubMed ID: 30290778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.
    Hatakeyama S; Fujita T; Murakami R; Suzuki Y; Sugiyama N; Yamamoto H; Okamoto A; Imai A; Tobisawa Y; Yoneyama T; Mori K; Yoneyama T; Hashimoto Y; Koie T; Narumi S; Ohyama C
    Transplant Proc; 2014; 46(2):445-8. PubMed ID: 24655984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Desensitization with antigen-specific immunoadsorption interferes with complement in ABO-incompatible kidney transplantation.
    Biglarnia AR; Nilsson B; Nilsson Ekdahl K; Tufveson G; Nilsson T; Larsson E; Wadström J
    Transplantation; 2012 Jan; 93(1):87-92. PubMed ID: 22113493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Borderline rejection in ABO-incompatible kidney transplantation.
    Sánchez-Escuredo A; Oppenheimer F; Solé M; Revuelta I; Cid J; Lozano M; Blasco M; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Paredes D; Musquera M; Ercilla G; Campistol JM; Diekmann F
    Clin Transplant; 2016 Aug; 30(8):872-9. PubMed ID: 27146439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The low dose of rituximab in ABO-incompatible kidney transplantation without a splenectomy: a single-center experience.
    Shirakawa H; Ishida H; Shimizu T; Omoto K; Iida S; Toki D; Tanabe K
    Clin Transplant; 2011; 25(6):878-84. PubMed ID: 21175849
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Initial experience with ABO-incompatible live donor renal transplantation.
    Tsai MK; Wu MH; Lo SC; Lai IR; Yu SC; Yuan RH; Lee PH
    J Formos Med Assoc; 2006 Sep; 105(9):775-9. PubMed ID: 16959628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experiences and problems pre-operative anti-CD20 monoclonal antibody infusion therapy with splenectomy and plasma exchange for ABO-incompatible living-donor liver transplantation.
    Usui M; Isaji S; Mizuno S; Sakurai H; Uemoto S
    Clin Transplant; 2007; 21(1):24-31. PubMed ID: 17302588
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ABO-incompatible kidney transplantation.
    Schousboe K; Titlestad K; Baudier F; Hansen LU; Bistrup C
    Dan Med Bull; 2010 Oct; 57(10):A4197. PubMed ID: 21040684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year protocol biopsies from ABO-incompatible renal allografts compared with a matched cohort of ABO-compatible allografts.
    Dörje C; Mjøen G; Strøm EH; Holdaas H; Jenssen T; Øyen O; Akkök ÇA; Cvancarova M; Midtvedt K; Reisaeter AV
    Clin Transplant; 2015 Mar; 29(3):268-76. PubMed ID: 25644963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Reuse of Immunoadsorption Columns in ABO-Incompatible Kidney Transplantation Is Efficient: The Swiss Experience.
    Schiesser M; Steinemann DC; Hadaya K; Huynh-Do U; Eisenberger U; Binet I; Fehr T; Dickenmann M
    Transplantation; 2015 May; 99(5):1030-5. PubMed ID: 25340594
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
    Ashimine S; Watarai Y; Yamamoto T; Hiramitsu T; Tsujita M; Nanmoku K; Goto N; Takeda A; Katayama A; Uchida K; Kobayashi T
    Kidney Int; 2014 Feb; 85(2):425-30. PubMed ID: 23945498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: Experience of one center.
    Melexopoulou C; Marinaki S; Liapis G; Skalioti C; Gavalaki M; Zavos G; Boletis JN
    World J Transplant; 2015 Dec; 5(4):329-37. PubMed ID: 26722661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes and complications following ABO-incompatible kidney transplantation performed after desensitization by semi-selective immunoadsorption - a retrospective study.
    Speer C; Kälble F; Nusshag C; Pego da Silva L; Schaier M; Becker LE; Klein K; Sommerer C; Beimler J; Leo A; Waldherr R; Mehrabi A; Süsal C; Zeier M; Morath C
    Transpl Int; 2019 Dec; 32(12):1286-1296. PubMed ID: 31322786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequent development of subclinical chronic antibody-mediated rejection within 1 year after renal transplantation with pre-transplant positive donor-specific antibodies and negative CDC crossmatches.
    Yamanaga S; Watarai Y; Yamamoto T; Tsujita M; Hiramitsu T; Nanmoku K; Goto N; Takeda A; Morozumi K; Katayama A; Saji H; Uchida K; Kobayashi T
    Hum Immunol; 2013 Sep; 74(9):1111-8. PubMed ID: 23792054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABO-incompatible kidney transplantation-proposal of an intensified apheresis strategy for patients with high initial isoagglutinine titers.
    Wilpert J; Geyer M; Teschner S; Schaefer T; Pisarski P; Schulz-Huotari C; Gropp A; Wisniewski U; Goebel H; Gerke P; Walz G; Donauer J
    J Clin Apher; 2007; 22(6):314-22. PubMed ID: 18095303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.